Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Anna Manturova Clear advanced filters
  • Current models suggest that DLK1 is an inhibitory ligand in the Notch pathway. Here, the authors show that DLK1 does not interact with Notch receptors, instead blocking Activin signaling via an interaction with Activin receptor type-2B.

    • Daniel Antfolk
    • Qianqian Ming
    • Vincent C. Luca
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-14
  • Lymphocyte activation gene-3 (LAG3) is an immune checkpoint protein recently approved as a target for anti-melanoma therapy. Here, the authors solve the structure of mouse LAG3 bound to MHC-II to show that LAG3 blocks MHC-II/CD4 interactions, thereby implicating a potential mechanism of LAG3-mediated immune suppression.

    • Qianqian Ming
    • Daniel Antfolk
    • Vincent C. Luca
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-11